Search Results - "Rocca, M. A."

Default-mode network dysfunction and cognitive impairment in progressive MS by ROCCA, M. A, VALSASINA, P, ABSINTA, M, RICCITELLI, G, RODEGHER, M. E, MISCI, P, ROSSI, P, FALINI, A, COMI, G, FILIPPI, M

“…This study explores default-mode network (DMN) abnormalities in patients with secondary progressive (SP) and primary progressive (PP) multiple sclerosis (MS)…”
Get full text

Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis by FILIPPI, M, ROCCA, M. A, CALABRESE, M, SORMANI, M. P, RINALDI, F, PERINI, P, COMI, G, GALLO, P

“…To generate and validate new MRI diagnostic criteria for multiple sclerosis (MS) taking into account not only white matter lesions but also intracortical…”
Get full text

Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis by Gobbi, C, Rocca, MA, Riccitelli, G, Pagani, E, Messina, R, Preziosa, P, Colombo, B, Rodegher, M, Falini, A, Comi, G, Filippi, M

“…Objectives: Involvement of selected central nervous system (CNS) regions has been associated with depression and fatigue in MS. We assessed whether specific…”
Get full text

A multicenter assessment of cervical cord atrophy among MS clinical phenotypes by ROCCA, M. A, HORSFIELD, M. A, COMI, G, FILIPPI, M, SALA, S, COPETTI, M, VALSASINA, P, MESAROS, S, MARTINELLI, V, CAPUTO, D, STOSIC-OPINCAL, T, DRULOVIC, J

“…In this multicenter study, a new semiautomatic method for segmenting the cervical cord from C2 to C5 was used to investigate the correlation between cord…”
Get full text

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration by Kearney, H, Rocca, MA, Valsasina, P, Balk, L, Sastre-Garriga, J, Reinhardt, J, Ruggieri, S, Rovira, A, Stippich, C, Kappos, L, Sprenger, T, Tortorella, P, Rovaris, M, Gasperini, C, Montalban, X, Geurts, JJG, Polman, CH, Barkhof, F, Filippi, M, Altmann, DR, Ciccarelli, O, Miller, DH, Chard, DT

“…Background: Understanding long-term disability in multiple sclerosis (MS) is a key goal of research; it is relevant to how we monitor and treat the disease…”
Get full text

The contribution of MRI in assessing cognitive impairment in multiple sclerosis by FILIPPI, M, ROCCA, M. A, BENEDICT, R. H. B, DELUCA, J, GEURTS, J. J. G, ROMBOUTS, S. A. R. B, RON, M, COMI, G

“…Cognitive impairment affects a large proportion of patients with multiple sclerosis (MS) and has a profound impact on their daily-life activities. Improving…”
Get full text

Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis by MESAROS, S, ROCCA, M. A, DRULOVIC, J, COMI, G, FILIPPI, M, KACAR, K, KOSTIC, J, COPETTI, M, STOSIC-OPINCAL, T, PREZIOSA, P, SALA, S, RICCITELLI, G, HORSFIELD, M. A

“…To assess the correlation between cognitive impairment and overall vs regional CNS damage, quantified using conventional and diffusion tensor (DT) MRI…”
Get full text

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI by GEURTS, J. J. G, ROOSENDAAL, S. D, ROCCA, M. A, WATTJES, M. P, YOUSRY, T. A, UITDEHAAG, B. M. J, BARKHOF, F, CALABRESE, M, CICCARELLI, O, AGOSTA, F, CHARD, D. T, GASS, A, HUERGA, E, MORAAL, B, PARETO, D

“…Different double inversion recovery (DIR) sequences are currently used in multiple sclerosis (MS) research centers to visualize cortical lesions, making it…”
Get full text

Voxelwise Assessment of the Regional Distribution of Damage in the Brains of Patients with Multiple Sclerosis and Fatigue by RICCITELLI, G, ROCCA, M. A, FORN, C, COLOMBO, B, COMI, G, FILIPPI, M

“…Fatigue affects up to 90% of patients with MS. We assessed the regional distribution of lesions and atrophy of the normal-appearing WM and GM in patients with…”
Get full text

Cortical lesions in primary progressive multiple sclerosis : A 2-year longitudinal MR study by CALABRESE, M, ROCCA, M. A, GALLO, P, FILIPPI, M, ATZORI, M, MATTISI, I, BERNARDI, V, FAVARETTO, A, BARACHINO, L, ROMUALDI, C, RINALDI, L, PERINI, P

“…In primary progressive multiple sclerosis (PPMS), a discrepancy exists between the modest brain white matter (WM) lesion burden and the severity of neurologic…”
Get full text

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis by AGOSTA, F, CHIO, A, COSOTTINI, M, DE STEFANO, N, FALINI, A, MASCALCHI, M, ROCCA, M. A, SILANI, V, TEDESCHI, G, FILIPPI, M

“…In patients with ALS, conventional MR imaging is frequently noninformative, and its use has been restricted to excluding other conditions that can mimic ALS…”
Get full text

Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial by Edan, G, Comi, G, Le Page, E, Leray, E, Rocca, M A, Filippi, M

“…ObjectivesThe long-term impact of interferon-beta-1b (IFN) might be improved by short-term immunosuppression with mitoxantrone (MITOX) in aggressive…”
Get full text

Altered functional and structural connectivities in patients with MS : A 3-T study by ROCCA, M. A, PAGANI, E, ABSINTA, M, VALSASINA, P, FALINI, A, SCOTTI, G, COMI, G, FILIPPI, M

“…To determine the functional and structural substrates of motor network dysfunction in patients with relapsing-remitting multiple sclerosis (RRMS). Using a 3-T…”
Get full text

Evidence of thalamic gray matter loss in pediatric multiple sclerosis by MESAROS, S, ROCCA, M. A, ABSINTA, M, GHEZZI, A, MILANI, N, MOIOLA, L, VEGGIOTTI, P, COMI, G, FILIPPI, M

“…We used voxel-based morphometry (VBM) to assess the pattern of regional gray matter (GM) loss in patients with pediatric multiple sclerosis (MS) and its…”
Get full text

Profiling cognitive–motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study by Veldkamp, R., D’hooge, M., Sandroff, B. M., DeLuca, J., Kos, D., Salter, A., Feinstein, A., Amato, M. P., Brichetto, G., Chataway, J., Farrell, R., Chiaravalloti, N. D., Dalgas, U., Filippi, M., Freeman, J., Motl, R. W., Meza, C., Inglese, M., Rocca, M. A., Cutter, G., Feys, P.

“…Background Performing cognitive–motor dual tasks (DTs) may result in reduced walking speed and cognitive performance. The effect in persons with progressive…”
Get full text

Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis by Sumowski, J. F., Rocca, M. A., Leavitt, V. M., Riccitelli, G., Sandry, J., DeLuca, J., Comi, G., Filippi, M.

“…Background and purpose Active engagement in intellectually enriching activities (e.g. reading, hobbies) builds ‘reserve’ against memory decline in elders and…”
Get full text

A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients by Agosta, F, Rocca, M A, Valsasina, P, Sala, S, Caputo, D, Perini, M, Salvi, F, Prelle, A, Filippi, M

“…Objective: To define the temporal evolution of intrinsic tissue damage and atrophy in the cervical cord and the brain portion of the corticospinal tracts (CST)…”
Get full text

MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy by FILIPPI, M, ROCCA, M. A

“…Recent pathologic and MR imaging studies have challenged the classic view of MS as a chronic inflammatory-demyelinating condition affecting solely the WM of…”
Get full text

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases by Ghezzi, A, Pozzilli, C, Grimaldi, LME, Moiola, L, Brescia-Morra, V, Lugaresi, A, Lus, G, Rinaldi, F, Rocca, MA, Trojano, M, Bianchi, A, Comi, G, Filippi, M

“…Background: Limited information is available on the use of natalizumab (NA) in pediatric multiple sclerosis (ped-MS) patients. Objective: The purpose of this…”
Get full text

Safety and efficacy of natalizumab in children with multiple sclerosis by GHEZZI, A, POZZILLI, C, SARCHIELLI, P, ZAFFARONI, M, COMI, G, GRIMALDI, L. M. E, BRESCIA MORRA, V, BORTOLON, F, CAPRA, R, FILIPPI, M, MOIOLA, L, ROCCA, M. A, ROTTOLI, M

“…To describe the effect of natalizumab in the treatment of subjects with active multiple sclerosis (MS) treated before the age of 18 years. Nineteen pediatric…”
Get full text